Non-hormonal antiprolactin drug in tablets .
Package containing 1 blister with 10 tablets .
Non-hormonal antiprolactin drug selectively inhibiting prolactin secretion at pituitary level thanks to its agonist activity on dopamine 2 receptors.
1) Treatment of pseudopregnancy.
2) Suppression of milk secretion due to:
Removal of the litter immediately after delivery.
Early weaning.
Post-ovariohysterectomy lactation.
In situations that may induce unwanted effects such as breast obstruction and/or mastitis.
3) Pituitary Cushing syndrome.
4) Heat synchronization.
5) Coadjuvant in the medical treatment of pyometra
.
Each tablet contains:
Cabergoline 100 mcg
Excipients q.s.
Treatment of pseudopregnancy and milk suppression:
Bitches: 5 mcg/kg every 24 h for 4 to 6 days.
Cats: 2.5 to 5 mcg/kg every 24 h for 4 to 6 days.
Treatment of Cushing syndrome in dogs: 70 mcg/kg per week distributed every 48 h.
Pregnancy. Hypersensitivity to cabergoline, cardiac and/or pulmonary fibrosis, valve diseases, severe liver disease.
Vomiting may occur and subsides adjusting the dose or administering it with food .
Do not use during lactation .
Use with caution in patients on antihypertensive treatment .